FMI’s Prognosis: The Bone Growth Stimulators Market Poised for Remarkable Growth at US$ 5.4 Billion by 2033

The bone growth stimulators market is poised for significant expansion, with its projected value set to increase from an estimated US$ 2.1 billion in 2023 to a noteworthy US$ 5.4 billion by 2033. This impressive growth is underpinned by a robust compound annual growth rate (CAGR) of 10.1% expected during this forecasted period.

The market’s upward trajectory can be attributed to the escalating incidence of fractures worldwide, which is projected to drive the demand for Bone Growth Stimulators in the years to come. Furthermore, the market is buoyed by the increasing prevalence of bone and joint-related conditions, a global trend favoring minimally invasive and non-invasive medical procedures, and the expanding geriatric population. These factors collectively contribute to the compelling prospects within the Bone Growth Stimulators Market.

Grab Your Complimentary Report Complete with Engaging Visuals.
https://www.futuremarketinsights.com/reports/sample/rep-gb-828

A bone growth stimulator’s best advantage is that it accelerates the entire process of bone healing, resulting in faster recovery, shorter hospitalisation, higher cost-effectiveness, and fewer infections.

According to a recent study conducted by the International Osteoporosis Foundation, statistics revealed that more than200 a million people are suffering from osteoporosis. Worldwide, 1 in 3 women over the age of 50 years and 1 in 5 men will experience osteoporotic fractures in their lifetime. These numbers are anticipated to increase at a fast pace in the assessment period, therefore, bolstering the demand for Bone Growth Stimulators worldwide.

Key Takeaways

• Because of an ageing population, rapid economic expansion in growing Asia-Pacific (APAC) countries, and an increase in the volume of spine surgeries, the Bone Growth Stimulators market in numerous Asia-Pacific countries is likely to grow rapidly over the forecast period.
• India is predicted to be the fastest-growing market in APAC, with a CAGR of 11.4%. Growth will be fueled by improvements in the country’s healthcare landscape.
• The US market for Bone Growth Stimulators is estimated to exceed US$ 2.2 billion by 2033.
• With a rise in medical tourism and a growing demand for less invasive procedures, the United Kingdom is expected to dominate the European Bone Growth Stimulators market in the next years. Sales are expected to account for 20.4% of the global market in 2022.
• The hospital segment is estimated to be valued more than US$ 743 million by 2028.

Methodology Details Just a Click Away!

https://www.futuremarketinsights.com/request-report-methodology/rep-gb-828

Competitive Landscape

The prominent players operating in the global Bone Growth Stimulators market are extensively investing in research and development activities in order to launch innovative and technologically advanced products that cater to an expanding customer base. In addition to that, dominant market players are heavily investing in mergers, acquisitions, collaborations, and partnerships to strengthen their distribution networks.

Some of the leading companies operating in the Bone Growth Stimulators Market are

• Zimmer Biomet Holdings Inc
• Bioventus LLC.
• DJO Global, Orthofix Holdings, Inc.
• Ossatec Benelux Ltd.
• IGEA
• Ito Co., Ltd.

More Insights into the Bone Growth Stimulators Market

The US is expected to dominate the North American region by garnering maximum sales in the global Bone Growth Stimulators market. The global market is anticipated to account for about 42.5% of the total market share in 2022. According to the CDC, around 1 out of every 4 US adults (23.7%, 58.5 million people) suffer from diagnosed arthritis. The incidence of arthritis and osteoarthritis is predicted to grow in the forthcoming years, which in turn will propel the demand for electrical Bone Growth Stimulators over the assessment period.

The UK is predicted to dominate the European Bone Growth Stimulators market in the forthcoming years, as it accounts for around 20.4% of the total market share in 2022. The growth is attributed to the growing preference for minimally invasive procedures and the rising popularity of medical tourism in the country.

Level Up Your Market Understanding – Buy Now!
https://www.futuremarketinsights.com/checkout/828

Bone Growth Stimulators Markets by Category

Product Type:

• Non-Invasive Bone Growth Stimulators
• Capacitive Coupling (CC) Devices
• Pulsed Electromagnetic Field (PEMF) Devices
• Combined Magnetic Field (CMF) Devices
• Ultrasound Bone Growth Stimulators
• Invasive Bone Growth Stimulators

Application:

• Trauma Injury and Fractures
• Spinal Fusion
• Osteogenesis

End User:

• Hospitals
• Orthopedic Clinics
• Ambulatory Surgical Centers
• Homecare settings

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube